Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Drug Pricing Legislation Efforts Headed Toward Spring Renewal? A Look Ahead

Executive Summary

Senate legislation taking aim at price increases faces uphill climb, but sponsors are hoping President Trump will mobilize more support among congressional Republicans in the coming year.

You may also be interested in...



Drug Pricing Reform In 2020 Gets Harder Due To Third Coronavirus Bill

Senate and House versions of a pending coronavirus stimulus package take off the table a key legislative vehicle lawmakers planned to use to push for bipartisan drug pricing reform until at least after the 2020 elections, signaling a potential reprieve for the pharmaceutical industry. 

Medicare Could Save More than $80bn With Price Inflation Rebates – CBO Score of Senate Bill

Nearly $70bn in savings over 10 years is expected to result from mandatory price inflation rebates for drugs covered by Medicare Part D.

Medicare Plan For Lowering Insulin Costs Takes Aim At Benefit Design Instead Of List Prices

The new payment demonstration in Part D reflects the increasing recognition that insurance benefit design has a major impact on insulin affordability.

Related Content

Topics

UsernamePublicRestriction

Register

PS141437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel